SIDNEY BRAGINSKYBiographyMr. Sidney Braginsky has been President, Chief Executive 0ffrcet and Chairman of theBoard of Atropcs Technology, LLC since July 2000. Atropos is the majority shareholderof Digilab LLC, the former molecular spectroscopy division of Bio-Rad acquired byAtropos in 2001. Atropos also is responsible for Double D (Devices and Diagnostics), aVenture Capital Frxrd. Mr. Braginsky served as Chairman and Managing Director ofDouble D and Chairman and CEO of Digilab LLC.Mr. Braginsky served as President of Olympus Americ4Inc. from October 1990 toDecember 1999. bthis role, he built a billion-dollar business focused on opticalproducts including cameras and scientific instruments (microscopes, endoscopes andchemistry analyzers). Mr. Braginsky also served as President and Chief OperalingOfficer of Mediscience Technology Corp., a designer and developer of diagnosticdevices.Currentiy, President of SterileWave, Board Member of Endgene, and Solidlook all inoptical endoscopy forming the new SterileS/ave LLC.Mr. Braginsky currently serves and has served on the boards of as Chairman or auditcommittee both private and public companies. He is now CEO-Chair for Digilab Co.p;Biop Medical; AceruMedical: EndoRobotics; Endogene; Endopix,Waveline Medicaladvisory; Solidl,ook Medical; Lumigene; Lumigetr Medical; Tomado Medical; LymphaticResearch Foundation; and has served on the boards of Electrooptical Systems lnc., nowMela Medical; Semrock; Estech, Cardiology; Response Biomedical; Diomed; and NovenPharmaceuticals, Invendo Medical Gmbh., DJO a Blackstone investment, SterileWaveEndo., ColdSteel Medical..Mr. Braginsky was the former Chairman of,lnternational Standards Organization's (ISO's)Optics and Electro-Optical Systems, representing DfN. and served as the U.S. Leader ofthe same ISO group.